C
Claudia Berbel
Researcher at University of Barcelona
Publications - 4
Citations - 277
Claudia Berbel is an academic researcher from University of Barcelona. The author has contributed to research in topics: Liver disease & Cirrhosis. The author has an hindex of 4, co-authored 4 publications receiving 147 citations. Previous affiliations of Claudia Berbel include Carlos III Health Institute.
Papers
More filters
Journal ArticleDOI
Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis
Macarena Simón-Talero,Davide Roccarina,Javier Martínez,Javier Martínez,Katharina Lampichler,Anna Baiges,Anna Baiges,Gavin Low,Elba Llop,Michael Praktiknjo,Martin H. Maurer,Alexander Zipprich,Michela Triolo,Guillaume Vangrinsven,R. Garcia-Martinez,R. Garcia-Martinez,Annette Dam,Avik Majumdar,Carmen Picón,Daniel Toth,Anna Darnell,Juan G. Abraldes,Marta López,Guido M. Kukuk,Aleksander Krag,Rafael Bañares,Rafael Bañares,Wim Laleman,Vincenzo La Mura,Vincenzo La Mura,Cristina Ripoll,Annalisa Berzigotti,Jonel Trebicka,Jose Luis Calleja,Puneeta Tandon,Virginia Hernández-Gea,Virginia Hernández-Gea,Thomas Reiberger,Agustín Albillos,Agustín Albillos,Emmanuel Tsochatzis,Salvador Augustin,Salvador Augustin,Joan Genescà,Joan Genescà,Sergi Quiroga,Dominic Yu,Luis Téllez,Mattias Mandorfer,Juan Carlos García-Pagán,Juan Carlos García-Pagán,Claudia Berbel,Claudia Berbel,José Ferrusquia,Michel Ble,Mari Angeles Garcia-Criado,Ernest Belmonte,Michael Ney,Cristina Margini,Stefania Casu,Giuseppe Murgia,Christiane Ludwig,Martin Rönsch,Dietrich Stoevesandt,Laura Carrion,Enrique Ramón Botella +65 more
TL;DR: The main outcomes were the incidence of complications of cirrhosis and mortality according to the presence of SPSS, and quality of life and transplantation-free survival were lower in patients with S PSS vs without.
Journal ArticleDOI
Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis.
Michael Praktiknjo,Macarena Simón-Talero,Julia Römer,Davide Roccarina,Javier Martínez,Katharina Lampichler,Anna Baiges,Gavin Low,Elba Llop,Martin H. Maurer,Alexander Zipprich,Michela Triolo,Geert Maleux,Annette Dam Fialla,Claus Dam,Judit Vidal-González,Avik Majumdar,Carmen Picón,Daniel Toth,Anna Darnell,Juan G. Abraldes,Marta López,Christian Jansen,Johannes Chang,Robert Schierwagen,Frank Erhard Uschner,Guido M. Kukuk,Carsten H. Meyer,Daniel Thomas,Karsten Wolter,Christian P. Strassburg,Wim Laleman,Vincenzo La Mura,Vincenzo La Mura,Cristina Ripoll,Annalisa Berzigotti,Jose Luis Calleja,Puneeta Tandon,Virginia Hernández-Gea,Thomas Reiberger,Agustín Albillos,Emmanuel Tsochatzis,Aleksander Krag,Joan Genescà,Jonel Trebicka,Sergi Quiroga,Dominic Yu,Luis Téllez,Mattias Mandorfer,Juan Carlos García-Pagán,Claudia Berbel,José Ferrusquia,Michel Ble,Mari Angeles Garcia-Criado,Ernest Belmonte,Michael Ney,Cristina Margini,Stefania Casu,Giuseppe Murgia,Christiane Ludwig,Franz Stangl +60 more
TL;DR: It is suggested that TSA >83mm2 increases the risk for oHE and mortality in liver cirrhosis and may have impact on clinical use of TSA/SPSS for risk stratification and clinical decision-making considering management of SPSS.
Journal ArticleDOI
Acute variceal bleeding: risk stratification and management (including TIPS)
TL;DR: The present chapter will focus on the initial management of patients with acute variceal bleeding, including general management and hemostatic therapies, as well as the available treatments in case of failure to control bleeding or development of rebleeding.
Journal ArticleDOI
Portal Hypertension Reverses Following Successful Antiviral Treatment for HCV: Fact or Fiction?
TL;DR: It is relevant to recognize that, despite achieving SVR and a reduction in portal pressure, CSPH and the risk of liver-related complications persist in a significant proportion of patients with advanced disease.